Literature DB >> 17380510

Solution structures, dynamics, and lipid-binding of the sterile alpha-motif domain of the deleted in liver cancer 2.

Hongyan Li1, King-Leung Fung, Dong-Yan Jin, Stephen S M Chung, Yick-Pang Ching, Irene Oi-lin Ng, Kong-Hung Sze, Ben C B Ko, Hongzhe Sun.   

Abstract

The deleted in liver cancer 2 (DLC2) is a tumor suppressor gene, frequently found to be underexpressed in hepatocellular carcinoma. DLC2 is a multidomain protein containing a sterile alpha-motif (SAM) domain, a GTPase-activating protein (GAP) domain, and a lipid-binding StAR-related lipid-transfer (START) domain. The SAM domain of DLC2, DLC2-SAM, exhibits a low level of sequence homology (15-30%) with other SAM domains, and appears to be the prototype of a new subfamily of SAM domains found in DLC2-related proteins. In the present study, we have determined the three-dimensional solution structure of DLC2-SAM using NMR methods together with molecular dynamics simulated annealing. In addition, we performed a backbone dynamics study. The DLC2-SAM packed as a unique four alpha-helical bundle stabilized by interhelix hydrophobic interactions. The arrangement of the four helices is distinct from all other known SAM domains. In contrast to some members of the SAM domain family which form either dimers or oligomers, both biochemical analyses and rotational correlation time (tau(c)) measured by backbone 15N relaxation experiments indicated that DLC2-SAM exists as a monomer in solution. The interaction of DLC2-SAM domain with sodium dodecyl sulfate (SDS) micelles and 1,2-dimyristoyl-sn-glycerol-3-phosphatidylglycerol (DMPG) phospholipids was examined by CD and NMR spectroscopic techniques. The DLC2-SAM exhibits membrane binding properties accompanied by minor loss of the secondary structure of the protein. Deletion studies showed that the self-association of DLC2 in vivo does not require SAM domain, instead, a protein domain consisting of residues 120-672 mediates the self-association of DLC2. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380510     DOI: 10.1002/prot.21361

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  17 in total

Review 1.  StarD13: a potential star target for tumor therapeutics.

Authors:  Leila Jaafar; Zeinab Chamseddine; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2020-04-09       Impact factor: 4.174

2.  DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.

Authors:  Rakesh Joshi; Lyugao Qin; Xuan Cao; Shanshan Zhong; Courtney Voss; Weiping Min; Shawn S C Li
Journal:  J Biol Chem       Date:  2019-12-05       Impact factor: 5.157

3.  A CC-SAM, for coiled coil-sterile α motif, domain targets the scaffold KSR-1 to specific sites in the plasma membrane.

Authors:  Dorothy Koveal; Natasha Schuh-Nuhfer; Daniel Ritt; Rebecca Page; Deborah K Morrison; Wolfgang Peti
Journal:  Sci Signal       Date:  2012-12-18       Impact factor: 8.192

4.  NMR studies of a heterotypic Sam-Sam domain association: the interaction between the lipid phosphatase Ship2 and the EphA2 receptor.

Authors:  Marilisa Leone; Jason Cellitti; Maurizio Pellecchia
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

5.  Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis.

Authors:  Tai On Yau; Thomas Ho Yin Leung; Sandra Lam; Oi Fung Cheung; Edmund Kwok Kwan Tung; Pek Lan Khong; Amy Lam; Sookja Chung; Irene Oi Lin Ng
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

Review 6.  Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility.

Authors:  T Y Kim; D Vigil; C J Der; R L Juliano
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

7.  Identifying polymer-forming SAM domains.

Authors:  Alejandro D Meruelo; James U Bowie
Journal:  Proteins       Date:  2009-01

8.  Deleted in liver cancer protein family in human malignancies (Review).

Authors:  D Lukasik; E Wilczek; A Wasiutynski; B Gornicka
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

9.  PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis.

Authors:  Frankie Chi Fat Ko; Lo-Kong Chan; Karen Man-Fong Sze; Yin-Shan Yeung; Edith Yuk-Ting Tse; Ping Lu; Ming-Hua Yu; Irene Oi-Lin Ng; Judy Wai Ping Yam
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  The Lipid Transfer Protein StarD7: Structure, Function, and Regulation.

Authors:  Jésica Flores-Martin; Viviana Rena; Sofía Angeletti; Graciela M Panzetta-Dutari; Susana Genti-Raimondi
Journal:  Int J Mol Sci       Date:  2013-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.